CRISPR Medicine News
Business News
About CRISPR Medicine News
Welcome to CRISPR Medicine News.
We are a global independent online media writing about gene therapy and genome editing.
Learn - Innovate - Access
CLINICAL TRIALS
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Familial Chylomicronemia Syndrome, FCS, (NCT07176923)
Sponsors:
CorrectSequence Therapeutics Co., Ltd
Sponsors:
CorrectSequence Therapeutics Co., Ltd
IND Enabling
Phase I
Phase II
Phase III